| Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force JS Smolen, FC Breedveld, GR Burmester, V Bykerk, M Dougados, ... Annals of the rheumatic diseases 75 (1), 3-15, 2016 | 1648 | 2016 |
| Diagnosis and relation to general health of shoulder disorders presenting to primary care AJK Ostor, CA Richards, AT Prevost, CA Speed, BL Hazleman Rheumatology 44 (6), 800-805, 2005 | 504 | 2005 |
| The effect of methotrexate on cardiovascular disease in patients with rheumatoid arthritis: a systematic literature review SL Westlake, AN Colebatch, J Baird, P Kiely, M Quinn, E Choy, AJK Ostor, ... Rheumatology 49 (2), 295-307, 2010 | 460 | 2010 |
| Immune-mediated inflammatory diseases (IMIDs) and biologic therapy: a medical revolution A Kuek, BL Hazleman, AJK Östör Postgraduate medical journal 83 (978), 251-260, 2007 | 394 | 2007 |
| Upadacitinib versus placebo or adalimumab in patients with rheumatoid arthritis and an inadequate response to methotrexate: results of a phase III, double‐blind, randomized … R Fleischmann, AL Pangan, IH Song, E Mysler, L Bessette, C Peterfy, ... Arthritis & rheumatology 71 (11), 1788-1800, 2019 | 380 | 2019 |
| Risk of adverse events including serious infections in rheumatoid arthritis patients treated with tocilizumab: a systematic literature review and meta-analysis of randomized … L Campbell, C Chen, SS Bhagat, RA Parker, AJK Oestoer Rheumatology 50 (3), 552-562, 2011 | 315 | 2011 |
| Tumour necrosis factor antagonists and the risk of cardiovascular disease in patients with rheumatoid arthritis: a systematic literature review SL Westlake, AN Colebatch, J Baird, N Curzen, P Kiely, M Quinn, E Choy, ... Rheumatology 50 (3), 518-531, 2011 | 282 | 2011 |
| BSR and BHPR rheumatoid arthritis guidelines on safety of anti-TNF therapies T Ding, J Ledingham, R Luqmani, S Westlake, K Hyrich, M Lunt, P Kiely, ... Rheumatology 49 (11), 2217-2219, 2010 | 251 | 2010 |
| Anti-tumor necrosis factor-α therapy reduces aortic inflammation and stiffness in patients with rheumatoid arthritis KM Mäki-Petäjä, M Elkhawad, J Cheriyan, FR Joshi, AJK Östör, FC Hall, ... Circulation 126 (21), 2473-2480, 2012 | 248 | 2012 |
| A systematic review of factors associated with non-adherence to treatment for immune-mediated inflammatory diseases E Vangeli, S Bakhshi, A Baker, A Fisher, D Bucknor, U Mrowietz, ... Advances in therapy 32, 983-1028, 2015 | 177 | 2015 |
| Non-infectious pulmonary toxicity of rituximab: a systematic review AV Hadjinicolaou, MK Nisar, H Parfrey, ER Chilvers, AJK Östör Rheumatology 51 (4), 653-662, 2012 | 170 | 2012 |
| Pulsed low-intensity ultrasound therapy for chronic lateral epicondylitis: a randomized controlled trial AP D'vaz, AJK Ostor, CA Speed, JR Jenner, M Bradley, AT Prevost, ... Rheumatology 45 (5), 566-570, 2006 | 168 | 2006 |
| Rituximab versus an alternative TNF inhibitor in patients with rheumatoid arthritis who failed to respond to a single previous TNF inhibitor: SWITCH-RA, a global, observational … P Emery, JE Gottenberg, A Rubbert-Roth, P Sarzi-Puttini, D Choquette, ... Annals of the rheumatic diseases 74 (6), 979-984, 2015 | 162 | 2015 |
| Lower gastrointestinal perforation in rheumatoid arthritis patients treated with conventional DMARDs or tocilizumab: a systematic literature review T Gout, AJK Östör, MK Nisar Clinical rheumatology 30, 1471-1474, 2011 | 158 | 2011 |
| Safety and effectiveness of upadacitinib or adalimumab plus methotrexate in patients with rheumatoid arthritis over 48 weeks with switch to alternate therapy in patients with … RM Fleischmann, MC Genovese, JV Enejosa, E Mysler, L Bessette, ... Annals of the rheumatic diseases 78 (11), 1454-1462, 2019 | 153 | 2019 |
| Non-infectious pulmonary complications of newer biological agents for rheumatic diseases—a systematic literature review AV Hadjinicolaou, MK Nisar, S Bhagat, H Parfrey, ER Chilvers, AJK Östör Rheumatology 50 (12), 2297-2305, 2011 | 145 | 2011 |
| Tocilizumab in patients with active rheumatoid arthritis and inadequate responses to DMARDs and/or TNF inhibitors: a large, open-label study close to clinical practice VP Bykerk, AJK Östör, J Alvaro-Gracia, K Pavelka, JAR Ivorra, ... Annals of the rheumatic diseases 71 (12), 1950-1954, 2012 | 130 | 2012 |
| Drug Points: Fatal exacerbation of rheumatoid arthritis associated fibrosing alveolitis in patients given infliximab AJK Ostor, AJ Crisp, MF Somerville, DGI Scott BMJ: British Medical Journal 329 (7477), 1266, 2004 | 121 | 2004 |
| Hypovitaminosis D among rheumatology outpatients in clinical practice M Mouyis, AJK Ostor, AJ Crisp, A Ginawi, DJ Halsall, N Shenker, ... Rheumatology 47 (9), 1348-1351, 2008 | 107 | 2008 |
| Contemporary treatment principles for early rheumatoid arthritis: a consensus statement PDW Kiely, AK Brown, CJ Edwards, DT O’Reilly, AJK Östör, M Quinn, ... Rheumatology 48 (7), 765-772, 2009 | 96 | 2009 |
